IFNG and neoplasm: Another in vivo murine study demonstrated that IL-4-mediated tumor suppression involved the production of the cytokine interferon-gamma (IFN-γ) [108], which supports subsequent findings indicating that IL-4-transfected tumor cell vaccines promoted Th1 immunity [109].